Seres Therapeutics (MCRB)

• Market cap: $72.5M
• 1 day: -1.19%
• 5 days: -6.02%
• 1 month: 6.24%
• 3 months: -16.41%
• 6 months: -56.81%
• Year to date: -50.56%
• 1 year: 5.64%
• 5 years: -98.15%
• 10 years: -98.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Employees: 66